BCM-475

N/A

Report date: 2025/03/25 13:31:29

Base Information

Drug NameBCM-475
Drug Alias Name布瑞哌唑口溶膜（博志研新）布瑞哌唑口溶膜（2.2类改良型）BCM475BCM-475
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShanghai Yunsheng Research New Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuroGen PharmaShanghai Yunsheng Research New Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A